8 Firms Bid To Lead Stock Suit Over Revoked COVID-19 Test
Lowenstein Sandler LLP and Robbins Geller Rudman & Dowd LLP appear to be leading the fight to helm a putative securities class action against a diagnostics company that had its COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article